Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Second clinical study for CTCE-0214

Dec. 20, 2005

CytRx and UMMS sign agreement for obesity and type diabetes targets

Dec. 20, 2005

Roche completes four pivotal studies for CERA in renal anemia

Dec. 20, 2005

Novartis terminates development of NKS-104

Dec. 20, 2005

Ezetimibe improves lipid parameters in HIV-infected subjects with dyslipidemia

Dec. 20, 2005

Recent patents report new therapeutic agents for metabolic disorders

Dec. 19, 2005

Companies patent compounds for diabetes, dysmenorrhea, male contraception, etc.

Dec. 16, 2005

APD-356 yields positive phase IIb results in obesity

Dec. 16, 2005

Radius acquires rights to Ipsen's BA-058 for osteoporosis

Dec. 15, 2005

Xechem acquires rights to five-membered heterocyclic antisickling compound

Dec. 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...